Parallel Advisors LLC Lowers Position in LHC Group, Inc. (NASDAQ:LHCG)

Parallel Advisors LLC trimmed its position in shares of LHC Group, Inc. (NASDAQ:LHCGGet Rating) by 54.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 156 shares of the health services provider’s stock after selling 189 shares during the quarter. Parallel Advisors LLC’s holdings in LHC Group were worth $26,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in LHCG. Comerica Bank lifted its holdings in LHC Group by 4.0% during the first quarter. Comerica Bank now owns 14,945 shares of the health services provider’s stock worth $2,499,000 after acquiring an additional 572 shares during the period. Citigroup Inc. boosted its holdings in shares of LHC Group by 58.2% in the 4th quarter. Citigroup Inc. now owns 9,875 shares of the health services provider’s stock worth $1,356,000 after buying an additional 3,632 shares during the last quarter. Renaissance Technologies LLC bought a new position in LHC Group during the fourth quarter valued at about $10,700,000. Mutual of America Capital Management LLC increased its holdings in LHC Group by 24.0% during the fourth quarter. Mutual of America Capital Management LLC now owns 75,413 shares of the health services provider’s stock worth $10,349,000 after buying an additional 14,574 shares during the last quarter. Finally, Spouting Rock Asset Management LLC raised its position in LHC Group by 10.6% in the fourth quarter. Spouting Rock Asset Management LLC now owns 19,256 shares of the health services provider’s stock worth $2,643,000 after acquiring an additional 1,843 shares during the period. Institutional investors own 89.65% of the company’s stock.

LHC Group Stock Performance

LHC Group stock opened at $163.24 on Monday. The firm has a fifty day simple moving average of $161.76 and a two-hundred day simple moving average of $150.81. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.47. LHC Group, Inc. has a twelve month low of $108.42 and a twelve month high of $216.65. The company has a market capitalization of $5.07 billion, a PE ratio of 50.70, a P/E/G ratio of 2.50 and a beta of 0.48.

LHC Group (NASDAQ:LHCGGet Rating) last released its earnings results on Wednesday, May 4th. The health services provider reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. LHC Group had a return on equity of 10.11% and a net margin of 4.44%. The company had revenue of $571.50 million during the quarter, compared to analyst estimates of $573.10 million. During the same quarter in the previous year, the company posted $1.39 EPS. LHC Group’s revenue for the quarter was up 8.9% on a year-over-year basis. Research analysts expect that LHC Group, Inc. will post 5.79 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on LHCG. Barclays increased their price target on LHC Group from $154.00 to $170.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 12th. Deutsche Bank Aktiengesellschaft downgraded shares of LHC Group from a “buy” rating to a “hold” rating and reduced their target price for the stock from $190.00 to $170.00 in a research note on Monday, April 25th. Credit Suisse Group cut shares of LHC Group from an “outperform” rating to a “neutral” rating and dropped their price target for the company from $181.00 to $170.00 in a research note on Wednesday, March 30th. Royal Bank of Canada lowered shares of LHC Group from an “outperform” rating to a “sector perform” rating and reduced their price objective for the company from $172.00 to $170.00 in a research note on Monday, April 4th. Finally, Benchmark cut LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, March 30th. Twelve analysts have rated the stock with a hold rating, According to data from MarketBeat, LHC Group presently has an average rating of “Hold” and a consensus target price of $167.33.

About LHC Group

(Get Rating)

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI).

See Also

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCGGet Rating).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.